COYA vs MCD · rev $3.6M vs P/E 23, rev $25.92B
Coya Therapeutics, Inc. Common Stock (COYA) versus McDonald’s Corporation (MCD) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
McDonald’s Corporation (MCD) is a restaurants company listed on NYSE. It is led by Chris Kempczinski.
Latest reported COYA revenue for 2024-12-31 was $3.6M. Net income was -$14.9M. Revenue was down 40.8% from 2023-12-31 to 2024-12-31. COYA currently screens at market cap $118.0M.
Latest reported MCD revenue for 2024-12-31 was $25.92B. Net income was $8.22B. Revenue was up 1.7% from 2023-12-31 to 2024-12-31. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
COYA currently screens at market cap $118.0M. MCD currently screens at market cap $201.66B and trailing P/E 23.4.
Not investment advice. Open the COYA and MCD stock pages for the full models.
Not investment advice.